Garret Berkich, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $974 and has fallen 89.0% since, to $108 in 2025.
Across 60 payments — averaging $25.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$245
- Stryker$134
- Boston Scientific$130
- Relievant Medsystems, Inc.$128
- Merz Pharmaceuticals, LLC$76
- Pfizer$75
- plus $730 from 18 others
What the payments were for
- Food & beverage$1,519100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 15 | $245 |
| Stryker | 3 | $134 |
| Boston Scientific | 2 | $130 |
| Relievant Medsystems, Inc. | 3 | $128 |
| Merz Pharmaceuticals, LLC | 2 | $76 |
| Pfizer | 4 | $75 |
| Biohaven Pharmaceuticals, Inc. | 4 | $72 |
| Abbott | 1 | $70 |
| AstraZeneca | 1 | $66 |
| Medtronic | 2 | $66 |
| Biodelivery Sciences International, Inc. | 3 | $54 |
| Si-bone, Inc. | 2 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Amgen(2 entities) | 2 | $35 |
| Nalu Medical, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $34 |
| Vertex | 1 | $33 |
| Tersera Therapeutics LLC | 2 | $30 |
| AbbVie(2 entities) | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 2 | $29 |
| SK Life Science, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Banner Life Sciences, LLC | 1 | $20 |
How this compares
$1,519 in reported general payments places this provider in the 65th percentile of 91 surgical providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 67 | $3,084 |
| Pregabalin | 19 | $1,098 |
| Gabapentin | 49 | $907 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $572 |
| Tizanidine Hcl | 42 | $525 |
| Baclofen | 37 | $525 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $397 |
| Oxycodone Hcl | 43 | $362 |
| Methocarbamol | 21 | $277 |
| Diclofenac Sodium | 38 | $261 |
| Cyclobenzaprine Hcl | 41 | $207 |
| Methylprednisolone | 27 | $148 |
| Meloxicam | 37 | $143 |
| Tramadol Hcl | 30 | $103 |
| Zolpidem Tartrate | 12 | $100 |
Paid to pharmacies, not to this prescriber.
Other surgical in Reno
- Kellie KoppReno$10K
- Curt EricksonReno$7K
- Gregory GravesReno$5K
- Corinna JewellReno$3K
- Davis AyersReno$3K
- Terri ElliottReno$1K
- Kalli MannosReno$1K
- Olivia AndersonReno$1K
- Renee CoveyReno$1K
- Samantha PerkinsReno$880
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.